Abstract Synovial fluid isolated from 16 patients with rheumatoid arthritis activated luminol dependent chemiluminescence in bloodstream neutrophils, and the maximal activity stimulated varied over a 50-fold range. In contrast, these same fluids only activated a much lower range (two-to threefold) of maximal rates of lucigenin dependent chemiluminescence and cytochrome c reduction, two assays which only measure oxidant secretion which is independent of myeloperoxidase. Over 95% of the luminol dependent chemiluminescence activated by all samples was inhibited by azide (indicating its dependence upon myeloperoxidase), but anti-(myeloperoxidase) IgG (which specifically inhibits only the extracellular activity of this enzyme) only inhibited the response stimulated by some samples: those fluids which activated the highest luminol dependent chemiluminescence also stimulated the greatest activity of an extracellular myeloperoxidase-H202 system. A clear correlation was shown to exist between the activity of myeloperoxidase already present in the fluids (after its secretion from neutrophils in situ within the rheumatoid joint) and the ability of the fluid to activate luminol dependent chemiluminescence. It is concluded, therefore, that all synovial fluid samples tested possess almost equivalent levels of a factor(s) which activated 0-2/H2O2 secretion and that the variations in the measured activity of the extracellular myeloperoxidase-H202 system are dependent upon the level of degranulation which had occurred within the joint.
Polymorphonuclear leucocytes (neutrophils) play a key part in host protection against invading microbial pathogens and may perform other immunoregulatory functions.' Because they are present in large numbers in the synovial fluid of patients with rheumatoid arthritis and other types of inflammatory joint disease and also possess a broad spectrum of cytotoxic processes it has been proposed that these cells become inappropriately activated within rheumatoid joints in a mistaken attempt to mount an antimicrobial response.2' Thus it has been suggested that neutrophil derived cytotoxic products provoke or exacerbate joint damage because naturally occurring host protection systems-for example, oxidant detoxifying enzymes such as catalase and superoxide dismutase, or antiproteinases-may be deficient within the inflamed joint.5 Indeed, evidence is now accumulating to support this concept that neutrophils have been activated within rheumatoid joints,''0 lending indirect support to this proposal. Central to this hypothesis is the presence within synovial fluid of factor(s) which can activate newly recruited neutrophils, and immune complexes present within these fluids are likely candidates for this role. " 12 When neutrophils become activated in vitro by soluble or particulate stimuli they can generate reactive oxidants either intracellularly or extracellularly.'"'5 Oxidant secretion may be necessary to kill non-phagocytosable pathogens and may also be important in the activation or deactivation of proinflammatory and antiinflammatory regulatory components. Intracellular oxidant generation may be restricted to within the phagolysosome in order to target their production towards the ingested pathogen, but it is intriguing to note that intracellular oxidant production can occur in response to soluble stimulants. Although the biological role of this latter production is unknown, it is unlikely to have a direct role in host tissue damage during inappropriate neutrophil activation in inflammation.
We have previously shown that neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis have biochemical characteristics to indicate that they have been both primed and activated in situ within joints. (only 20% of the control response after 35 minutes' incubation) and a maximal value of 20 mV was obtained by one hour. These data thus show that firstly, this high activity synovial fluid activates the myeloperoxidase-H202 system (by virtue of the azide sensitivity) and that secondly, much of this activity is extracellular (because it is inhibited by anti-(myeloperoxidase) IgG).
The low activity synovial fluid (fig 2B) activated 15 mV of chemiluminescence, and this also was almost completely inhibited by the addition of azide. After stimulation of neutrophils in the presence of anti-(myeloperoxidase) IgG, slightly greater luminol dependent chemiluminescence was generated. These observations have several implications. Firstly, as with the high activity fluid (fig 2A) , the myeloperoxidase-H202 system is activated. Secondly, because anti-(myeloperoxidase) IgG did not inhibit this response, much of this activity must be intracellular and hence inaccessible to the IgG. Thirdly, the rates of intracellular, myeloperoxidase-dependent oxidant production (trace 2c) stimulated by both the high and low activity fluids are virtually equivalent. Fourthly, inhibition of the extracellular myeloperoxidase enhances the duration of oxidant production; we have previously shown that this can occur because a product of the myeloperoxidase-H202 system inhibits (and chemiluminescence were mainly due to differences in the extracellular activity of the myeloperoxidase-H202 system. This extracellular activity may be due either to variations in the rates of degranulation stimulated by these fluids or else may be due to variations in the activity of myeloperoxidase already present in these fluids-that is, after activation of degranulation of this enzyme in vivo within the joint. The table shows that the myeloperoxidase activity (detected by the guaiacol assay) present in these synovial fluids ranged from <0 5 mU/mI to 20 mU/ml. Figure 3 shows a remarkable correlation between maximal rates of luminol dependent chemiluminescence stimulated by these fluids and the activity ofmyeloperoxidase already present in them after in vivo degranulation. These data strongly suggest that the rate of activity of the potentially tissue damaging extracellular myeloperoxidase-H202 system is largely dependent upon the degree of activity of secreted myeloperoxidase present in these fluids. Activation of reactive oxidant production by neutrophils is a complex process entailing agonist/receptor occupancy, signal transduction, second messenger production, and the trans-location and integration of NADPH oxidase components into an active complex.' This oxidase may become activated on the plasma membrane or else on the membrane (derived from the plasma membrane) surrounding the phagolysosome. Concomitant with oxidase activation is the subcellular movement of cytoplasmic granules containing cytotoxic enzymes (including myeloperoxidase), and these granules may fuse either with the intracellular phagocytic vesicle or else with the plasma membrane.34 This latter process will result in oxidant secretion and release of granule enzymes extracellularly. Therefore, before the role of neutrophil derived oxidants in the pathology of inflammatory joint disease can be established it is essential that firstly, molecular parameters to establish neutrophil activation are defined and secondly, that intracellular and extracellular events are clearly distinguished.
Discussion
We have previously established methodologies'3 to distinguish between (a) intracellular and extracellular oxidant secretion and (b) myeloperoxidase dependent and independent processes. We have also shown that myeloperoxidase is detected in synovial fluid from patients with rheumatoid arthritis, and that this enzyme is in a form which suggests that it has been cosecreted from neutrophils in parallel with reactive oxidants,25 indicating that an extracellular myeloperoxidase-H202 system may play an important part in tissue damage. Thus Experiments using azide to inhibit myeloperoxidase (or using salicylhydroxamic acid, unpublished observations) showed that over 95% of the luminol dependent chemiluminescence was mediated by the myeloperoxidase-H202 system (fig 2) . When anti-(myeloperoxidase) IgG was used specifically to inhibit only the extracellular activity of this system, however, only those fluids which activated high rates of luminol dependent chemiluminescence were affected. Interestingly, the residual activity measured after inhibition of the extracellular enzyme was remarkably similar for all synovial fluid samples, further confirming the suggestion that the level of activity of the oxidase activating factor is remarkably similar in all samples tested. These observations clearly indicate that the wide variations in luminol dependent chemiluminescence activated by the different synovial fluid samples correlated with the extracellular activity of myeloperoxidase and not with variations in levels of a factor(s) which activated the NADPH oxidase. Furthermore, the kinetics of oxidant generation were altered in the presence of anti-(myeloperoxidase) IgG: we have previously shown that a product of the myeloperoxidase-H202 system inhibits the duration of oxidant production during the respiratory burst,33 35 and hence released myeloperoxidase may serve to self regulate oxidant secretion during inflammatory activation.
Two possibilities may account for this wide variation in extracellular activity of the myeloperoxidase-H202 system. Firstly, there may be wide variations in the levels of a factor in these synovial fluids which activates degranulation of myeloperoxidase: we could not, however, detect any correlation between the ability of the different synovial fluids to activate degranulation and their ability to activate luminol dependent chemiluminescence (unpublished observations). Secondly, it was a possibility that functionally active myeloperoxidase was already present in these synovial fluids at different levels (resulting from activation of degranulation of this enzyme within the joint) and that the introduction of this enzyme into the assay was responsible for the variation in extracellular activity. A remarkable correlation was shown to exist between the rates of luminol dependent chemiluminescence and myeloperoxidase activities in the different samples (fig 3) 
